July of 2019 has been an active month for the Patent Trial and Appeal Board (PTAB). The PTAB issued a Trial Practice Guide Update that addresses: The July 2019 Update can be accessed on the PTAB website....more
Cited Statutory Sections: 101 and 103 -
This appeal concerned 10 inter partes reviews (IPRs) filed by petitioners Neptune Generics, Fresenius Kabi USA and Mylan Laboratories against all of the claims of U.S. Patent No....more
A bipartisan group of Senators and Representatives recently released a framework for amending Section 101. The group includes Senator Chris Coons (D-Del.) and Senator Thom Tillis (R-N.C.), as well as Representative Doug...more
4/25/2019
/ Abstract Ideas ,
Innovation Patent ,
Intellectual Property Protection ,
Legislative Agendas ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Post-Grant Review ,
Proposed Legislation ,
Regulatory Agenda ,
Rulemaking Process ,
Section 101